Hyperbaric Treatment of Delayed Radiation Injury

Earn CME/CE in your profession:


Continuing Education Activity

There will be 1.2 million cases of invasive cancer diagnosed in the United States this year. Half of those patients will receive radiation therapy as part of their treatment program. Serious radiation complications will occur in 5% of patients receiving radiation therapy. This represents about 30,000 cases per year.Often, delayed effects of radiation are diagnosed when an additional insult to the tissue such as surgery or trauma occurs. This activity explains how to properly evaluate radiation induced injury and highlights the role of the interprofessional team in caring for patients with this condition.

Objectives:

  • Describe the pathophysiology of radiation induced tissue injury.
  • Review the presentation of patients with radiation induced tissue injury.
  • Summarize the treatment options for radiation induced tissue injury.
  • Outline the importance of enhancing care coordination among the interprofessional team to ensure proper evaluation and management of radiation induced tissue injury.

Introduction

There will be 1.2 million cases of invasive cancer diagnosed in the United States this year. Half of those patients will receive radiation therapy as part of their treatment program. Serious radiation complications will occur in 5% of patients receiving radiation therapy. This represents about 30,000 cases per year.

Radiation is dosed in Rads and Grays:

1 rad = 1 centigray (cGy) = 100 ergs of energy per gm of tissue

Often, delayed effects of radiation are diagnosed when an additional insult to the tissue such as surgery or trauma occurs.

Etiology

The biological effect of radiation on the tissues includes DNA damage, lipid peroxidation, and protein denaturation. The cellular consequences include cell death and dysfunction. In virtually all tissues that demonstrate late effects of radiation, there is a characteristic obliterative endarteritis. Current research into the etiology of delayed radiation injury has shown that the process of radiation injury begins during the time of radiation treatment and involves the elaboration of many bioactive substances, especially fibrogenic cytokines. TGF-beta is the most commonly studied cytokine associated with late effects of radiation as well as several other cytokines.[1][2]

Acute/Subacute radiation patterns usually develop after 5000 centigray (cGy).

Occurs acutely (near immediate) and the result of cellular toxicity by free radical damage to cellular DNA.

Subacute injuries (2 to 3 months post radiation) usually involve the lung.[3]

Delayed injuries occur more than 6 months to years after completion of radiation treatment. These are precipitated by further injuries in the previously irradiated field such as surgery or trauma. Delayed radiation injury often develops after 6500 centigray (cGy).[4]

Epidemiology

Approximately one-third of patients in the United States who received hyperbaric oxygen therapy is being treated for late effects of radiation therapy (LERT). Major advances have been made in the past 50 years in the treatment and prognosis of many cancers. Many cancers which were once considered to be universally terminal, are now routinely survivable. Unfortunately, ionizing radiation when used to treat cancer is a double-edged sword. It is highly effective at killing the malignancy and curing cancer. However, it is indiscriminate, and despite best efforts and intentions, there is no way to protect nonmalignant tissues from being irreparably damaged by the ionizing radiation. Thus the patient is fortunate to be cured of cancer, but may be faced with delayed radiation injury months or even decades after the treatment is complete.[5][3]

Many times, delayed radiation injuries are precipitated by an additional tissue insult such as trauma or surgery.[6]

Pathophysiology

Diffuse injury pattern related to the isodosing concept. The tumor is treated as a spheroidal mass with the most number of target cells at the center. A boost dose is given to the center of the tumor. At incremental distances from the center of the tumor, the mass is less; therefore, the delivered dose is less. However, the patient develops an additional diffuse area of injury from beam divergence. Radiation wounds demonstrate a progressive, proliferative endarteritis. This is an obliterative process that destroys the tissue blood supply. The tissue ends up chronically hypoxic, fibrotic, and with a dearth of blood vessels.[7]

There is no satisfactory treatment of radiation necrosis using conventional therapy.  It is difficult if not impossible to provide adequate nutrients and oxygen to the devascularized tissues. Surgical reconstruction of previously irradiated tissue has a very high failure rate due to poor healing.

The 3 Hs of previously irradiated tissue[8][9]

  • Hypoxia
  • Hypovascularity
  • Hypocellularity

Delayed radiation injury is a problem of impaired and inadequate tissue turnover and wound healing.

Histopathology

Two mechanisms of injury have been proposed and supported by animal and in vitro studies. The first postulates direct damage to small vessel endothelium, being a tissue that exhibits rapid turnover, through interaction with the radiation-induced reactive oxidative species. The resulting debris interrupts the vascular flow, a process known as endarteritis obliterans. The other model describes a delayed process initiated at the time of radiation with the release of bioactive, fibrogenic cytokines inhibiting parenchymal and stem cells and causing the extensive fibrosis seen in several damaged irradiated tissue. This is known as the fibro-atrophic effect.[10][11]

Toxicokinetics

The effects of ionizing radiation on soft tissues are permanent and ever-changing. Patients treated with radiation therapy for prostate cancer can develop post radiation cystitis and hematuria even 20 years after the completion of the radiation therapy. Patients treated for prostate and colon cancers can develop proctitis as well as cystitis due to late effects of ionizing radiation.[12][13][14][15]

History and Physical

Patients who develop delayed effects of radiation present most commonly with radiation cystitis, radiation proctitis, vaginal radionecrosis, soft tissue radionecrosis, or laryngeal radionecrosis.[16][17]

Patients who have undergone radiation to the head and neck for soft tissue and palate or bone cancers may develop osteoradionecrosis of the jaw. This can be manifested by exposed bone (usually the maxilla or mandible) in previously irradiated tissue that has failed to close spontaneously or with treatment for at least six months. These patients may also develop chronic draining sinus tracts and fistulae from the bone.[18][8][19]

It is important to document when the radiation treatment was completed and what the total dose was given.

Total doses of more than 6500 cGy are associated with the development of osteoradionecrosis and soft tissue radionecrosis.

Note if the patient has undergone recent bone biopsies, salvage surgery, trauma due to an oral or dental prosthesis, dental or periodontal disease, or extraction.[20][21][7][22]

Often, women who have received radiation for breast cancer develop post-radiation tissue fibrosis and hypovascularity of the chest-wall tissue which can make successful reconstruction and healing difficult, if not impossible.[23][24]

Evaluation

Patients presenting for hyperbaric oxygen treatment for late or delayed effects of radiation should have a formal consultation with the hyperbaric physician and treatment team. Information needed to determine the diagnosis and develop a treatment plan include:

  • Radiation therapy record: Specifically the total dose received and the dates the therapy was given
  • Any history of chemotherapy and agents used
  • Recent imaging results such as PET, CT, or MRI scans to document that the patient is currently cancer-free
  • Reports and records from the referring physician requesting the hyperbaric medicine consultation.[25]

Treatment / Management

Treatment protocols vary depending on the treated tissue.

Robert Marx, DDS did most of the work elucidating the benefit of hyperbaric oxygen for treatment of osteoradionecrosis of the mandible in patients who received head and neck radiation. Osteoradionecrosis of the jaw is the result of an aseptic, avascular necrosis of the bone. Marx showed that for hyperbaric oxygen to be consistently successful, it must be combined with surgery and antibiotic therapy. The major principals elucidated by Marx in the treatment and prevention of ORN include an emphasis on pre-surgical hyperbaric oxygen to improve tolerance to surgical wounding. These patients typically receive 20 pre-extraction treatments followed by ten post-extraction hyperbaric oxygen treatments.[26][27]

Laryngeal necrosis and other soft tissue necrosis of the head and neck due to late effects of radiation therapy have been successfully treated with hyperbaric oxygen to improve tissue quality both preoperatively and postoperatively and to improve survival of surgical flaps in previously irradiated head and neck tissues.[28]

A growing body of literature supports the use of hyperbaric oxygen therapy in the prevention of radiation injury. This is usually in the setting of proposed surgery within a previously irradiated field where the likelihood of complications and difficult wound healing is high.[29]

At present, a reasonable approach is to provide adjunctive hyperbaric oxygen treatments when surgery in heavily irradiated tissue bed is planned.[30][31]

Differential Diagnosis

  • Bowen’s disease
  • Burns
  • Basal carcinoma
  • Cold injuries
  • Early diabetes
  • Marjolin’s ulcer
  • Obesity
  • Polyarteritis nodosa
  • Systemic lupus erythematosus
  • Venous stasis

Enhancing Healthcare Team Outcomes

Delayed radiation injuries (soft tissue and bony necrosis) is a CMS-approved diagnosis for hyperbaric oxygen therapy. Depending on the individual patient diagnosis and the proposed surgery, the patient may receive from 20 to 60 hyperbaric oxygen treatments to treat and mitigate the symptoms of LERT. An interprofessional team of specialty trained hyperbaric nurse and clinician should monitor the patient during treatment. [Level V]


Details

Editor:

Marc Robins

Updated:

7/17/2023 8:43:09 PM

References


[1]

Lam G, Fontaine R, Ross FL, Chiu ES. Hyperbaric Oxygen Therapy: Exploring the Clinical Evidence. Advances in skin & wound care. 2017 Apr:30(4):181-190. doi: 10.1097/01.ASW.0000513089.75457.22. Epub     [PubMed PMID: 28301358]

Level 3 (low-level) evidence

[2]

Baines CR, McGuiness W, O'Rourke GA. An integrative review of skin assessment tools used to evaluate skin injury related to external beam radiation therapy. Journal of clinical nursing. 2017 Apr:26(7-8):1137-1144. doi: 10.1111/jocn.13430. Epub 2017 Feb 7     [PubMed PMID: 27322721]


[3]

Fleckenstein K, Zgonjanin L, Chen L, Rabbani Z, Jackson IL, Thrasher B, Kirkpatrick J, Foster WM, Vujaskovic Z. Temporal onset of hypoxia and oxidative stress after pulmonary irradiation. International journal of radiation oncology, biology, physics. 2007 May 1:68(1):196-204     [PubMed PMID: 17448873]


[4]

Feldmeier JJ. Hyperbaric oxygen therapy and delayed radiation injuries (soft tissue and bony necrosis): 2012 update. Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc. 2012 Nov-Dec:39(6):1121-39     [PubMed PMID: 23342770]


[5]

Al-Waili NS, Butler GJ, Beale J, Hamilton RW, Lee BY, Lucas P. Hyperbaric oxygen and malignancies: a potential role in radiotherapy, chemotherapy, tumor surgery and phototherapy. Medical science monitor : international medical journal of experimental and clinical research. 2005 Sep:11(9):RA279-89     [PubMed PMID: 16127374]


[6]

Allen S, Kilian C, Phelps J, Whelan HT. The use of hyperbaric oxygen for treating delayed radiation injuries in gynecologic malignancies: a review of literature and report of radiation injury incidence. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2012 Oct:20(10):2467-72. doi: 10.1007/s00520-012-1379-x. Epub 2012 Jan 14     [PubMed PMID: 22246598]


[7]

Adkinson C, Anderson T, Chavez J, Collier R, MacLeod S, Nicholson C, Odland R, Vellis P. Hyperbaric oxygen therapy: a meeting place for medicine and dentistry. Minnesota medicine. 2005 Aug:88(8):42-5     [PubMed PMID: 16225335]


[8]

Thariat J, de Mones E, Darcourt V, Poissonnet G, Marcy PY, Guevara N, Bozec A, Ortholan C, Santini J, Bensadoun RJ, Dassonville O. [Teeth and irradiation: dental care and treatment of osteoradionecrosis after irradiation in head and neck cancer]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 2010 Apr:14(2):137-44. doi: 10.1016/j.canrad.2009.09.010. Epub 2010 Feb 26     [PubMed PMID: 20189427]


[9]

Chrcanovic BR, Reher P, Sousa AA, Harris M. Osteoradionecrosis of the jaws--a current overview--Part 2: dental management and therapeutic options for treatment. Oral and maxillofacial surgery. 2010 Jun:14(2):81-95. doi: 10.1007/s10006-010-0205-1. Epub     [PubMed PMID: 20145963]

Level 3 (low-level) evidence

[10]

Feldmeier JJ, Heimbach RD, Davolt DA, McDonough MJ, Stegmann BJ, Sheffield PJ. Hyperbaric oxygen in the treatment of delayed radiation injuries of the extremities. Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc. 2000 Spring:27(1):15-9     [PubMed PMID: 10813435]


[11]

Feldmeier JJ. Hyperbaric oxygen for delayed radiation injuries. Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc. 2004 Spring:31(1):133-45     [PubMed PMID: 15233169]


[12]

Mayer R, Klemen H, Quehenberger F, Sankin O, Mayer E, Hackl A, Smolle-Juettner FM. Hyperbaric oxygen--an effective tool to treat radiation morbidity in prostate cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2001 Nov:61(2):151-6     [PubMed PMID: 11690680]


[13]

Henson C. Chronic radiation proctitis: issues surrounding delayed bowel dysfunction post-pelvic radiotherapy and an update on medical treatment. Therapeutic advances in gastroenterology. 2010 Nov:3(6):359-65. doi: 10.1177/1756283X10371558. Epub     [PubMed PMID: 21180615]

Level 3 (low-level) evidence

[14]

Fink D, Chetty N, Lehm JP, Marsden DE, Hacker NF. Hyperbaric oxygen therapy for delayed radiation injuries in gynecological cancers. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2006 Mar-Apr:16(2):638-42     [PubMed PMID: 16681739]

Level 2 (mid-level) evidence

[15]

Feldmeier JJ, Heimbach RD, Davolt DA, Court WS, Stegmann BJ, Sheffield PJ. Hyperbaric oxygen an adjunctive treatment for delayed radiation injuries of the abdomen and pelvis. Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc. 1996 Dec:23(4):205-13     [PubMed PMID: 8989850]


[16]

Feldmeier JJ, Davolt DA, Court WS, Onoda JM, Alecu R. Histologic morphometry confirms a prophylactic effect for hyperbaric oxygen in the prevention of delayed radiation enteropathy. Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc. 1998 Summer:25(2):93-7     [PubMed PMID: 9670434]


[17]

Feldmeier JJ, Jelen I, Davolt DA, Valente PT, Meltz ML, Alecu R. Hyperbaric oxygen as a prophylaxis for radiation-induced delayed enteropathy. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 1995 May:35(2):138-44     [PubMed PMID: 7569022]


[18]

Curi MM, Cardoso CL, Benites AFC, Bueno PM. Delayed tongue necrosis simultaneous with bilateral osteoradionecrosis of the jaw secondary to head and neck irradiation. Oral surgery, oral medicine, oral pathology and oral radiology. 2017 Feb:123(2):e28-e32. doi: 10.1016/j.oooo.2016.10.010. Epub 2016 Oct 15     [PubMed PMID: 27993571]


[19]

Mihalcea O, Arnold AC. Side effect of head and neck radiotherapy: optic neuropathy. Oftalmologia (Bucharest, Romania : 1990). 2008:52(1):36-40     [PubMed PMID: 18714488]


[20]

Neal MS. The effects of radiotherapy on maxillofacial tissue. Journal of wound care. 2000 May:9(5):239-42     [PubMed PMID: 11933335]


[21]

Delanian S, Chatel C, Porcher R, Depondt J, Lefaix JL. Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline-tocopherol-clodronate combination (PENTOCLO): a phase II trial. International journal of radiation oncology, biology, physics. 2011 Jul 1:80(3):832-9. doi: 10.1016/j.ijrobp.2010.03.029. Epub 2010 Jul 16     [PubMed PMID: 20638190]


[22]

Hom DB, Unger GM, Pernell KJ, Manivel JC. Improving surgical wound healing with basic fibroblast growth factor after radiation. The Laryngoscope. 2005 Mar:115(3):412-22     [PubMed PMID: 15744149]


[23]

Enomoto M, Yagishita K, Okuma K, Oyaizu T, Kojima Y, Okubo A, Maeda T, Miyamoto S, Okawa A. Hyperbaric oxygen therapy for a refractory skin ulcer after radical mastectomy and radiation therapy: a case report. Journal of medical case reports. 2017 Jan 4:11(1):5. doi: 10.1186/s13256-016-1168-0. Epub 2017 Jan 4     [PubMed PMID: 28049509]

Level 3 (low-level) evidence

[24]

Feldmeier JJ, Heimbach RD, Davolt DA, Court WS, Stegmann BJ, Sheffield PJ. Hyperbaric oxygen as an adjunctive treatment for delayed radiation injury of the chest wall: a retrospective review of twenty-three cases. Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc. 1995 Dec:22(4):383-93     [PubMed PMID: 8574126]

Level 2 (mid-level) evidence

[25]

Feldmeier JJ, Hampson NB. A systematic review of the literature reporting the application of hyperbaric oxygen prevention and treatment of delayed radiation injuries: an evidence based approach. Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc. 2002 Spring:29(1):4-30     [PubMed PMID: 12507182]

Level 1 (high-level) evidence

[26]

Marx RE, Ames JR. The use of hyperbaric oxygen therapy in bony reconstruction of the irradiated and tissue-deficient patient. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons. 1982 Jul:40(7):412-20     [PubMed PMID: 7045303]


[27]

Myers RA, Marx RE. Use of hyperbaric oxygen in postradiation head and neck surgery. NCI monographs : a publication of the National Cancer Institute. 1990:(9):151-7     [PubMed PMID: 1692972]


[28]

Balogh JM, Sutherland SE. Osteoradionecrosis of the mandible: a review. The Journal of otolaryngology. 1989 Aug:18(5):245-50     [PubMed PMID: 2671406]


[29]

Marx RE, Johnson RP, Kline SN. Prevention of osteoradionecrosis: a randomized prospective clinical trial of hyperbaric oxygen versus penicillin. Journal of the American Dental Association (1939). 1985 Jul:111(1):49-54     [PubMed PMID: 3897335]

Level 1 (high-level) evidence

[30]

Tong AC, Leung AC, Cheng JC, Sham J. Incidence of complicated healing and osteoradionecrosis following tooth extraction in patients receiving radiotherapy for treatment of nasopharyngeal carcinoma. Australian dental journal. 1999 Sep:44(3):187-94     [PubMed PMID: 10592563]


[31]

Guernsey LM, Clark JM. Hyperbaric oxygen therapy with subtotal extirpation surgery in the management of radionecrosis of the mandible. International journal of oral surgery. 1981:10(Suppl 1):168-77     [PubMed PMID: 6807874]